Cart

“Open-Label Study of Atypical Neuroleptic Quetiapine for Treatment of Borderline Personality Disorder: Impulsivity as Main Target PDF” has been added to your cart. View cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item	Thumbnail image	Product	Price	Quantity	Subtotal
×		Efficacy, Safety, and Gradual Discontinuation of Clonazepam in Panic Disorder: A Placebo-Controlled, Multicenter Study Using Optimized Dosages PDF	$40.00	Efficacy, Safety, and Gradual Discontinuation of Clonazepam in Panic Disorder: A Placebo-Controlled, Multicenter Study Using Optimized Dosages PDF quantity	$40.00
×		Tiagabine for the Treatment of Generalized Anxiety Disorder: A Randomized, Open-Label, Clinical Trial With Paroxetine as a Positive Control PDF	$40.00	Tiagabine for the Treatment of Generalized Anxiety Disorder: A Randomized, Open-Label, Clinical Trial With Paroxetine as a Positive Control PDF quantity	$40.00
×		Co-occurrence of Serious or Undiagnosed Medical Conditions With Bipolar Disorder Preventing Clinical Trial Randomization: A Case Series PDF	$40.00	Co-occurrence of Serious or Undiagnosed Medical Conditions With Bipolar Disorder Preventing Clinical Trial Randomization: A Case Series PDF quantity	$40.00
×		Patient Compliance to a New Enteric-Coated Weekly Formulation of Fluoxetine During Continuation Treatment of Major Depressive Disorder PDF	$40.00	Patient Compliance to a New Enteric-Coated Weekly Formulation of Fluoxetine During Continuation Treatment of Major Depressive Disorder PDF quantity	$40.00
×		Correlation Between Different Levels of Placebo Response Rate and Clinical Trial Outcome in Major Depressive Disorder: A Meta-Analysis PDF	$40.00	Correlation Between Different Levels of Placebo Response Rate and Clinical Trial Outcome in Major Depressive Disorder: A Meta-Analysis PDF quantity	$40.00
×		A Randomized, Double-Blind, Fixed-Dose Comparison of Paroxetine and Placebo in the Treatment of Generalized Social Anxiety Disorder PDF	$40.00	A Randomized, Double-Blind, Fixed-Dose Comparison of Paroxetine and Placebo in the Treatment of Generalized Social Anxiety Disorder PDF quantity	$40.00
×		Sexual Function and Satisfaction in the Treatment of Chronic Major Depression With Nefazodone, Psychotherapy, and Their Combination PDF	$40.00	Sexual Function and Satisfaction in the Treatment of Chronic Major Depression With Nefazodone, Psychotherapy, and Their Combination PDF quantity	$40.00
×		Treatment of Depression With Methylphenidate in Patients Difficult to Wean From Mechanical Ventilation in the Intensive Care Unit PDF	$40.00	Treatment of Depression With Methylphenidate in Patients Difficult to Wean From Mechanical Ventilation in the Intensive Care Unit PDF quantity	$40.00
×		High-Dose Sertraline Strategy for Nonresponders to Acute Treatment for Obsessive-Compulsive Disorder: A Multicenter Double-Blind Trial PDF	$40.00	High-Dose Sertraline Strategy for Nonresponders to Acute Treatment for Obsessive-Compulsive Disorder: A Multicenter Double-Blind Trial PDF quantity	$40.00
×		Efficacy and Safety of Intramuscular Aripiprazole in Patients With Acute Agitation: A Randomized, Double-Blind, Placebo-Controlled Trial PDF	$40.00	Efficacy and Safety of Intramuscular Aripiprazole in Patients With Acute Agitation: A Randomized, Double-Blind, Placebo-Controlled Trial PDF quantity	$40.00
×		Effects of Nefazodone on Body Weight: A Pooled Analysis of Selective Serotonin Reuptake Inhibitor and Imipramine-Controlled Trials. PDF	$40.00	Effects of Nefazodone on Body Weight: A Pooled Analysis of Selective Serotonin Reuptake Inhibitor and Imipramine-Controlled Trials. PDF quantity	$40.00
×		Optimizing the Detection of Bipolar II Disorder in Outpatient Private Practice: Toward a Systematization of Clinical Diagnostic Wisdom PDF	$40.00	Optimizing the Detection of Bipolar II Disorder in Outpatient Private Practice: Toward a Systematization of Clinical Diagnostic Wisdom PDF quantity	$40.00
×		Long-Term Weight Gain in Patients Treated With Open-Label Olanzapine in Combination With Fluoxetine for Major Depressive Disorder PDF	$40.00	Long-Term Weight Gain in Patients Treated With Open-Label Olanzapine in Combination With Fluoxetine for Major Depressive Disorder PDF quantity	$40.00
×		Lithium Use, but Not Valproate Use, Is Associated With a Higher Risk of Chronic Kidney Disease in Older Adults With Mental Illness PDF	$40.00	Lithium Use, but Not Valproate Use, Is Associated With a Higher Risk of Chronic Kidney Disease in Older Adults With Mental Illness PDF quantity	$40.00
×		Valproate Efficacy for Agitation Management in a Patient With Paroxysmal Sympathetic Hyperactivity Due to Traumatic Brain Injury PDF	$40.00	Valproate Efficacy for Agitation Management in a Patient With Paroxysmal Sympathetic Hyperactivity Due to Traumatic Brain Injury PDF quantity	$40.00
×		Divalproex Monotherapy in the Treatment of Bipolar Offspring With Mood and Behavioral Disorders and at Least Mild Affective Symptoms PDF	$40.00	Divalproex Monotherapy in the Treatment of Bipolar Offspring With Mood and Behavioral Disorders and at Least Mild Affective Symptoms PDF quantity	$40.00
×		Pregnancy as a Major Determinant for Discontinuation of Antidepressants: An Analysis of Data From The Health Improvement Network PDF	$40.00	Pregnancy as a Major Determinant for Discontinuation of Antidepressants: An Analysis of Data From The Health Improvement Network PDF quantity	$40.00
×		Open-Label Study of Atypical Neuroleptic Quetiapine for Treatment of Borderline Personality Disorder: Impulsivity as Main Target PDF	$40.00	Open-Label Study of Atypical Neuroleptic Quetiapine for Treatment of Borderline Personality Disorder: Impulsivity as Main Target PDF quantity	$40.00
Coupon:

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.

Cart totals

Subtotal	$720.00
Total	$720.00

Proceed to checkout